Table 2. Early-onset cardiovascular findings according to the type of leukemia.
| Description of the heart condition | Acute lymphoblastic leukemia | Acute myeloid leukemia | TOTAL | ||
|---|---|---|---|---|---|
| Standard risk n: 14 | Intermediate risk n: 42 | High risk n: 38 | n: 18 | n: 112 | |
| CDRCT (FEVI <53%) | 0 (0%) | 2(1.8%) | 11(9.8%) | 7(6.3%) | 20(17.9%) |
| ECG abnormalities | 1(0.9%) | 16(14.3%) | 9(8.0%) | * 5(4.4%) | 31(27.6%) |
| Pericardial effusion | 2 (1.8%) | 0 | 7(6.3%) | * 5(4.5%) | 14(12.5%) |
| Valvular insufficiency | 0 | 0 | 2(1.8%) | * 5(4.5%) | 7 (6.2%) |
| Arterial hypertension | 2 (1.8%) | 5(4.5%) | 7(6.3%) | 0 | 14 (12.5%) |
| Pulmonary hypertension | 1 (1.8%) | 5(4.5%) | 9 (8.0%) | 2(1.8%) | 17 (15.1%) |
| No abnormal cardiovascular findings | 8 (57.1%) | 9 (21.4%) | 5 (13.1%) | 5(27.7%) | 27 (24.1%) |
* Patients may have combined electrocardiographic and echocardiographic abnormalities or electrocardiographic abnormalities on more than one evaluation. CDRCT: Cardiac dysfunction related to cancer therapy